Talisman Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.21M Sell
13,113
-19
-0.1% -$4.43K 2.58% 11
2025
Q4
$2.72M Sell
13,132
-84
-0.6% -$16.6K 2.11% 11
2025
Q3
$2.45M Buy
13,216
+19
+0.1% +$3.25K 2.03% 11
2025
Q2
$2.02M Buy
13,197
+27
+0.2% +$4.15K 1.84% 15
2025
Q1
$2.18M Buy
13,170
+355
+3% +$55.5K 2.24% 9
2024
Q4
$1.85M Sell
12,815
-148
-1% -$22.9K 1.97% 12
2024
Q3
$2.09M Buy
12,963
+26
+0.2% +$4.14K 2.2% 11
2024
Q2
$1.89M Buy
12,937
+2,365
+22% +$352K 2.18% 12
2024
Q1
$1.67M Sell
10,572
-8
-0.1% -$1.27K 2.1% 11
2023
Q4
$1.66M Buy
10,580
+49
+0.5% +$7.51K 2.46% 10
2023
Q3
$1.64M Buy
10,531
+1,001
+11% +$165K 2.84% 9
2023
Q2
$1.58M Buy
9,530
+225
+2% +$36.3K 2.69% 9
2023
Q1
$1.44M Buy
9,305
+979
+12% +$158K 2.61% 9
2022
Q4
$1.47M Buy
+8,326
New +$1.44M 3.13% 6

Other funds holding JNJ

Talisman Wealth Advisors's JNJ Position: Q1 2026 in Review

Talisman Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 0.14% in Q1 2026, selling an estimated $4.43K and leaving 13,113 shares worth $3.21M. The position accounts for 2.58% of the portfolio, ranked #11.

Talisman Wealth Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Talisman Wealth Advisors held 13,113 shares of Johnson & Johnson worth $3.21M as of Q1 2026.
  • Talisman Wealth Advisors sold 19 Johnson & Johnson shares in Q1 2026, an estimated $4.43K.
  • Johnson & Johnson made up 2.58% of Talisman Wealth Advisors's portfolio in Q1 2026, its #11 holding.
  • Talisman Wealth Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Talisman Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.